{{Rsnum
|rsid=4803817
|Gene=PPP1R13L
|Chromosome=19
|position=45404702
|Orientation=plus
|GMAF=0.3021
|Gene_s=CD3EAP,PPP1R13L
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 60.2 | 36.3 | 3.5
| HCB | 46.0 | 44.5 | 9.5
| JPT | 58.9 | 40.2 | 0.9
| YRI | 32.7 | 52.4 | 15.0
| ASW | 45.6 | 47.4 | 7.0
| CHB | 46.0 | 44.5 | 9.5
| CHD | 54.1 | 37.6 | 8.3
| GIH | 52.5 | 39.6 | 7.9
| LWK | 40.0 | 44.5 | 15.5
| MEX | 22.4 | 56.9 | 20.7
| MKK | 38.5 | 48.1 | 13.5
| TSI | 61.8 | 33.3 | 4.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22351191
|Title=Hapmap-based evaluation of ERCC2, PPP1R13L, and ERCC1 and lung cancer risk in a Chinese population
}}

{{PMID Auto
|PMID=24140460
|Title=HapMap-based study identifies risk sub-region on chromosome 19q13.3 in relation to lung cancer among Chinese
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}